Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Novel antifungal discovered by Takara Shuzo

April 4, 1997

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

April 4, 1997

Phase I/II results of MedImmune's MEDI-493 reported

April 3, 1997

IVAX's generic acyclovir tentatively approved

April 3, 1997

Stromectol available in U.S. for parasitic infections

April 3, 1997

Uriach discloses new antifungal agents

April 3, 1997

IntraBiotics/Synt:em to develop protegrin analogues

April 2, 1997

FDA tentatively approves generic acyclovir

April 2, 1997

Takeda reports new carbapenems

April 1, 1997

Antimicrobial agents disclosed by Maruho

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...